Hypothesis

Transiently coupling senolytic removal of dysfunctional cells with LSD1‑driven global DNA demethylation, followed by targeted activation of mitophagy regulators and a brief OSKM pulse, recreates the germline’s damage‑clearance → epigenetic erasure → chromatin remodeling → pluripotency reactivation sequence and markedly improves somatic tissue fitness.

Mechanistic Rationale

The germline maintains fidelity not by superior repair but by enforcing ruthless quality checkpoints at each reproductive bottleneck: apoptosis eliminates genomically unstable cells, mitophagy purges damaged mitochondria, and TET/LSD1‑mediated demethylation erases epigenetic noise before chromatin patterns are re‑established. Somatic cells retain the molecular machinery for these steps but lack the coordinated, high‑frequency activation that the germline enjoys. Recent work shows ectopic LSD1 expression in C. elegans somatic lineages erases aberrant chromatin memory and rescues transgenerational sterility【https://pmc.ncbi.nlm.nih.gov/articles/PMC4098867/】, while mitochondrial stress signaling can be amplified by PINK1/PRK2 activation to drive selective mitophagy【https://pmc.ncbi.nlm.nih.gov/articles/PMC9255434/】. By first clearing senescent cells with senolytics (e.g., dasatinib + quercetin)【https://doi.org/10.1016/j.ebiom.2017.03.027】, we reduce the load of cells that would resist reprogramming. Subsequent LSD1 expression then performs a genome‑wide erasure analogous to the germline’s ~90% DNA methylation loss, resetting histone marks and permitting re‑expression of mitophagy and telomere maintenance genes. A brief, low‑dose OSKM exposure thereafter reactivates a pluripotency‑like state without triggering tumorigenesis, mirroring the germline’s timed chromatin remodeling before telomerase reactivation.

Experimental Design

1. Mouse model: Progeroid Ercc1‑/Δ mice (accelerated aging) receive four weekly cycles of:
   • Senolytic treatment (dasatinib 5 mg/kg + quercetin 50 mg/kg, i.p.).
   • Inducible, soma‑specific LSD1 overexpression (tet‑ON system, 48 h pulse).
   • Mitochondrial stress boost via AAV9‑mediated PINK1/PRK2 co‑expression (24 h).
   • Transient OSKM expression (doxycycline‑inducible, 24 h).
2. Controls: vehicle, senolytic‑only, LSD1‑only, OSKM‑only, and full sequence without mitophagy boost.
3. Readouts (at 4‑week intervals): telomere length (qFISH), senescence biomarkers (p16^INK4a, SA‑β‑gal), mitochondrial membrane potential (TMRM), global 5‑mC and H3K4me2 levels (Western blot), germline‑gene expression (DDX4, STRA8), and functional assays (grip strength, treadmill endurance, frailty index).
4. Longevity cohort: track median and 90th percentile survival.

Predicted Outcomes

• Mice receiving the full sequential protocol will show longer telomeres, reduced senescence burden, enhanced mitochondrial respiration, and partial re‑activation of germline‑associated transcripts compared with any single‑intervention group.
• Functional healthspan measures will improve by ≥30 % relative to controls, with a statistically significant extension of median lifespan (p < 0.05, log‑rank test).
• Omitting the mitophagy boost will blunt the gains, indicating that mitochondrial quality control is a necessary downstream effector of the epigenetic reset.

Falsifiability

If the sequential intervention fails to improve any of the aforementioned biomarkers or does not extend lifespan beyond senolytic‑only treatment, the hypothesis that germline‑style damage clearance → epigenetic erasure → mitophagy priming → transient pluripotency recapitulation is a viable somatic rejuvenation strategy would be refuted. Conversely, a dose‑dependent rescue that correlates with LSD1 activity and mitophagy flux would support the mechanistic claim that somatic cells can be endowed with a germline‑grade editing budget through defined, inducible molecular steps.